Related Experiment Video
Updated: May 2, 2026

Strategies for Study of Neuroprotection from Cold-preconditioning
Published on: September 2, 2010
T-type calcium channel blockers as neuroprotective agents
Benjamin J Kopecky1, Ruqiang Liang, Jianxin Bao
1Department of Otolaryngology, Center for Aging, Washington University School of Medicine, 4560 Clayton Avenue, St. Louis, MO, 63110, USA.
T-type calcium channel blockers show promise for neuroprotection. This review examines existing drugs and novel selective compounds, exploring their potential mechanisms and evidence for brain cell protection.
Area of Science:
- Neuroscience
- Pharmacology
- Cardiovascular Research
Background:
- T-type calcium channels are crucial in neuronal, cardiovascular, and endocrine tissues.
- Dysregulation of these channels is linked to various diseases.
- Calcium channel blockers are widely used clinically for diverse conditions.
Purpose of the Study:
- To review the neuroprotective effects of T-type calcium channel blockers.
- To discuss both established drugs and novel, selective compounds.
- To explore the molecular mechanisms underlying neuroprotection.
Main Methods:
- Review of in vitro and in vivo studies on T-type calcium channel blockers.
- Analysis of existing literature on drug efficacy and selectivity.
- Examination of research on newly developed selective chemical compounds.
Main Results:
- T-type calcium channel blockers exhibit potential neuroprotective properties.
- Current blockers may affect multiple targets, complicating attribution of effects.
- Newly developed compounds offer greater selectivity for T-type calcium channels.
Conclusions:
- T-type calcium channel blockers warrant further investigation for neuroprotective applications.
- Selective blockers may offer a more targeted therapeutic approach.
- Understanding molecular mechanisms is key to optimizing their use in neurological conditions.
Related Concept Videos
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...

